• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEW
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SCHEDULE 13G filed by Zepp Health Corporation

    7/18/25 4:31:09 PM ET
    $ZEPP
    Computer Manufacturing
    Technology
    Get the next $ZEPP alert in real time by email



    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549


    SCHEDULE 13G


    UNDER THE SECURITIES EXCHANGE ACT OF 1934
    Zepp Health Corp

    (Name of Issuer)


    Class A Ordinary Shares, par value $0.0001 per share

    (Title of Class of Securities)


    98945L204

    (CUSIP Number)


    07/17/2025

    (Date of Event Which Requires Filing of this Statement)


    Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
    Checkbox not checked   Rule 13d-1(b)
    Checkbox checked   Rule 13d-1(c)
    Checkbox not checked   Rule 13d-1(d)






    SCHEDULE 13G

    CUSIP No.
    98945L204


    1Names of Reporting Persons

    Point72 Asset Management, L.P.
    2Check the appropriate box if a member of a Group (see instructions)

    Checkbox not checked  (a)
    Checkbox checked  (b)
    3Sec Use Only
    4Citizenship or Place of Organization

    DELAWARE
    Number of Shares Beneficially Owned by Each Reporting Person With:
    5Sole Voting Power

    0.00
    6Shared Voting Power

    6,472,224.00
    7Sole Dispositive Power

    0.00
    8Shared Dispositive Power

    6,472,224.00
    9Aggregate Amount Beneficially Owned by Each Reporting Person

    6,472,224.00
    10Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

    Checkbox not checked
    11Percent of class represented by amount in row (9)

    5.7 %
    12Type of Reporting Person (See Instructions)

    PN

    Comment for Type of Reporting Person:  Represented by 404,514 ADSs (as defined in Item 2(a)).


    SCHEDULE 13G

    CUSIP No.
    98945L204


    1Names of Reporting Persons

    Point72 Capital Advisors, Inc.
    2Check the appropriate box if a member of a Group (see instructions)

    Checkbox not checked  (a)
    Checkbox checked  (b)
    3Sec Use Only
    4Citizenship or Place of Organization

    DELAWARE
    Number of Shares Beneficially Owned by Each Reporting Person With:
    5Sole Voting Power

    0.00
    6Shared Voting Power

    6,472,224.00
    7Sole Dispositive Power

    0.00
    8Shared Dispositive Power

    6,472,224.00
    9Aggregate Amount Beneficially Owned by Each Reporting Person

    6,472,224.00
    10Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

    Checkbox not checked
    11Percent of class represented by amount in row (9)

    5.7 %
    12Type of Reporting Person (See Instructions)

    CO

    Comment for Type of Reporting Person:  Represented by 404,514 ADSs.


    SCHEDULE 13G

    CUSIP No.
    98945L204


    1Names of Reporting Persons

    Steven A. Cohen
    2Check the appropriate box if a member of a Group (see instructions)

    Checkbox not checked  (a)
    Checkbox checked  (b)
    3Sec Use Only
    4Citizenship or Place of Organization

    UNITED STATES
    Number of Shares Beneficially Owned by Each Reporting Person With:
    5Sole Voting Power

    0.00
    6Shared Voting Power

    6,472,224.00
    7Sole Dispositive Power

    0.00
    8Shared Dispositive Power

    6,472,224.00
    9Aggregate Amount Beneficially Owned by Each Reporting Person

    6,472,224.00
    10Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

    Checkbox not checked
    11Percent of class represented by amount in row (9)

    5.7 %
    12Type of Reporting Person (See Instructions)

    IN

    Comment for Type of Reporting Person:  Represented by 404,514 ADSs.


    SCHEDULE 13G

    Item 1. 
    (a)Name of issuer:

    Zepp Health Corp
    (b)Address of issuer's principal executive offices:

    Edisonweg 44 - B08, 4207 HG Gorinchem, The Netherlands
    Item 2. 
    (a)Name of person filing:

    This statement is filed by: (i) Point72 Asset Management, L.P. ("Point72 Asset Management") with respect to the class A ordinary shares, par value $0.0001 per share ("Class A Ordinary Shares"), of Zepp Health Corporation (the "Issuer") held, in the form of American Depositary Shares ("ADSs"), by Point72 Associates, LLC, an investment fund it manages ("Point72 Associates"); (ii) Point72 Capital Advisors, Inc. ("Point72 Capital Advisors Inc.") with respect to the Class A Ordinary Shares held, in the form of ADSs, by Point72 Associates; and (iii) Steven A. Cohen ("Mr. Cohen") with respect to the Class A Ordinary Shares beneficially owned, in the form of ADSs, by Point72 Asset Management and Point72 Capital Advisors Inc. Point72 Hong Kong Limited, an advisor under common control with Point72 Asset Management, acts as a sub-advisor with respect to a portion of the Class A Ordinary Shares reported herein. There is no CUSIP number assigned to the Class A Ordinary Shares. The CUSIP Number 98945L204 has been assigned to the ADSs of the Issuer, which are quoted on the New York Stock Exchange under the symbol "ZEPP." Each ADS represents 16 Class A Ordinary Shares. Point72 Asset Management, Point72 Capital Advisors Inc., and Mr. Cohen have entered into a Joint Filing Agreement, a copy of which is filed with this Schedule 13G as Exhibit 99.1, pursuant to which they have agreed to file this Schedule 13G jointly in accordance with the provisions of Rule 13d-1(k) of the Securities Exchange Act of 1934 (the "Act").
    (b)Address or principal business office or, if none, residence:

    The address of the principal business office of Point72 Asset Management, Point72 Capital Advisors Inc., and Mr. Cohen is 72 Cummings Point Road, Stamford, CT 06902.
    (c)Citizenship:

    Point72 Asset Management is a Delaware limited partnership. Point72 Capital Advisors Inc. is a Delaware corporation. Mr. Cohen is a United States citizen.
    (d)Title of class of securities:

    Class A Ordinary Shares, par value $0.0001 per share
    (e)CUSIP No.:

    98945L204
    Item 3.If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
    (a)Checkbox not checked   Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
    (b)Checkbox not checked   Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
    (c)Checkbox not checked   Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
    (d)Checkbox not checked   Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
    (e)Checkbox not checked   An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
    (f)Checkbox not checked   An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
    (g)Checkbox not checked   A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
    (h)Checkbox not checked   A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
    (i)Checkbox not checked   A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
    (j)Checkbox not checked   A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J),
           please specify the type of institution:
    (k)Checkbox not checked   Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
     
    Item 4.Ownership
    (a)Amount beneficially owned:

    The information required by Item 4(a) is set forth in Row 9 of the cover page for each of the Reporting Persons and is incorporated herein by reference. Such information is as of the close of business on July 17, 2025. Point72 Asset Management, Point72 Capital Advisors Inc., and Mr. Cohen own directly no Class A Ordinary Shares. Pursuant to an investment management agreement, Point72 Asset Management maintains investment and voting power with respect to the securities held by Point72 Associates. Point72 Capital Advisors Inc. is the general partner of Point72 Asset Management. Mr. Cohen controls each of Point72 Asset Management and Point72 Capital Advisors Inc. The filing of this statement should not be construed as an admission that any of the foregoing persons or any Reporting Person is, for the purposes of Section 13 of the Act, the beneficial owner of the Class A Ordinary Shares reported herein.
    (b)Percent of class:

    5.7%
    (c)Number of shares as to which the person has:
     (i) Sole power to vote or to direct the vote:

    The information required by Item 4(c)(i) is set forth in Row 5 of the cover page for each of the Reporting Persons and is incorporated herein by reference. Such information is as of the close of business on July 17, 2025.

     (ii) Shared power to vote or to direct the vote:

    The information required by Item 4(c)(ii) is set forth in Row 6 of the cover page for each of the Reporting Persons and is incorporated herein by reference. Such information is as of the close of business on July 17, 2025.

     (iii) Sole power to dispose or to direct the disposition of:

    The information required by Item 4(c)(iii) is set forth in Row 7 of the cover page for each of the Reporting Persons and is incorporated herein by reference. Such information is as of the close of business on July 17, 2025.

     (iv) Shared power to dispose or to direct the disposition of:

    The information required by Item 4(c)(iv) is set forth in Row 8 of the cover page for each of the Reporting Persons and is incorporated herein by reference. Such information is as of the close of business on July 17, 2025.

    Item 5.Ownership of 5 Percent or Less of a Class.
     
    Item 6.Ownership of more than 5 Percent on Behalf of Another Person.
     
    If any other person is known to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, such securities, a statement to that effect should be included in response to this item and, if such interest relates to more than 5 percent of the class, such person should be identified. A listing of the shareholders of an investment company registered under the Investment Company Act of 1940 or the beneficiaries of employee benefit plan, pension fund or endowment fund is not required.


    Point72 Associates has the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, more than 5 percent of the outstanding Class A Ordinary Shares.
    Item 7.Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
     
    Not Applicable
    Item 8.Identification and Classification of Members of the Group.
     
    Not Applicable
    Item 9.Notice of Dissolution of Group.
     
    Not Applicable

    Item 10.Certifications:
     
    By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11.

        SIGNATURE 
     
    After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

     
    Point72 Asset Management, L.P.
     
    Signature:/s/ Jason M. Colombo
    Name/Title:Jason M. Colombo, Authorized Person
    Date:07/18/2025
     
    Point72 Capital Advisors, Inc.
     
    Signature:/s/ Jason M. Colombo
    Name/Title:Jason M. Colombo, Authorized Person
    Date:07/18/2025
     
    Steven A. Cohen
     
    Signature:/s/ Jason M. Colombo
    Name/Title:Jason M. Colombo, Authorized Person
    Date:07/18/2025
    Exhibit Information

    Exhibit 99.1: Joint Filing Agreement

    Get the next $ZEPP alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ZEPP

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $ZEPP
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Amazfit Ambassador Ruth Croft Claims Victory at the 2025 UTMB

    Pro Ultra Trail Runner dominated the UTMB race powered by Amazfit's Helio Strap and the newly launched Amazfit T-Rex 3 Pro smartwatch Amazfit, a leading global smart wearable brand by Zepp Health (NYSE:ZEPP), is proud to celebrate Ruth Croft's achievement at the 2025 UTMB, earning first place and completing the UTMB with a time of 22 hours, 56 minutes, and 23 seconds. She is the first female to win OCC, CCC, and now UTMB. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250905921121/en/Amazfit is proud to celebrate Ruth Croft's achievement at the 2025 UTMB, earning first place and completing the UTMB with a time of 22 hours, 56

    9/5/25 5:00:00 AM ET
    $ZEPP
    Computer Manufacturing
    Technology

    Amazfit T-Rex 3 Pro Smartwatch Launches Featuring a Rugged Titanium Design and Integrated Flashlight

    Engineered for endurance athletes, the T-Rex 3 Pro is available in two sizes and adds enhanced offline mapping with auto route planning Amazfit, a leading global smart wearable brand by Zepp Health (NYSE:ZEPP), today announces the Amazfit T-Rex 3 Pro designed for trailrunners, endurance athletes, and outdoor adventurers. As the newest member of the T-Rex 3 family, the T-Rex 3 Pro builds on its predecessor with upgraded materials, enhanced mapping, flashlight, built-in speaker and mic, a sapphire glass screen and more. PRESS KIT AVAILABLE HERE This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250905482261/en/As the newest member o

    9/5/25 4:30:00 AM ET
    $ZEPP
    Computer Manufacturing
    Technology

    Zepp Health Acquires Core Assets of Wild.AI to Expand Support for Female Athletes Across Life Stages

    Zepp Health (NYSE:ZEPP), the parent company of Amazfit, today announced it has acquired the core assets and intellectual property of Wild.AI, a pioneering women's wellness platform focused on optimizing female performance through hormone-informed coaching. The acquisition was completed at the end of August and includes Wild.AI's proprietary technology and select members of its leadership team. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250904422306/en/ZEPP), the parent company of Amazfit, today announced it has acquired the core assets and intellectual property of Wild.AI, a pioneering women's wellness platform focused on op

    9/4/25 6:42:00 PM ET
    $ZEPP
    Computer Manufacturing
    Technology

    $ZEPP
    SEC Filings

    View All

    Amendment: SEC Form 144/A filed by Zepp Health Corporation

    144/A - Zepp Health Corp (0001720446) (Subject)

    9/8/25 2:58:55 PM ET
    $ZEPP
    Computer Manufacturing
    Technology

    Amendment: SEC Form SCHEDULE 13G/A filed by Zepp Health Corporation

    SCHEDULE 13G/A - Zepp Health Corp (0001720446) (Subject)

    8/7/25 10:14:20 AM ET
    $ZEPP
    Computer Manufacturing
    Technology

    SEC Form 6-K filed by Zepp Health Corporation

    6-K - Zepp Health Corp (0001720446) (Filer)

    8/4/25 6:01:15 AM ET
    $ZEPP
    Computer Manufacturing
    Technology

    $ZEPP
    Leadership Updates

    Live Leadership Updates

    View All

    NFL Running Back Derrick Henry Joins Amazfit as Athlete Ambassador

    Henry to utilize Amazfit products to optimize health, recovery and performance as he enters his 10th NFL season Amazfit, a leading global smart wearables brand owned by Zepp Health (NYSE:ZEPP), announced Baltimore Ravens running back Derrick Henry as the newest elite athlete to join its growing roster of ambassadors. Known for his rare combination of speed and strength, Henry will utilize Amazfit wearables to power every phase of his training, recovery and sleep as he prepares for his 10th NFL season. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250718322498/en/Derrick Henry is the newest elite athlete to join Amazfit's grow

    7/18/25 9:00:00 AM ET
    $ZEPP
    Computer Manufacturing
    Technology

    Italian Tennis Star Jasmine Paolini Joins Amazfit as Latest Athlete Ambassador

    Paolini to Wear Amazfit Smart Wearables to Enhance Performance and Recovery. Amazfit logo to appear on Paolini's on-court apparel. Amazfit, a leading global smart wearables brand owned by Zepp Health (NYSE:ZEPP), today announced the signing of Italian tennis sensation and World No. 4 Jasmine Paolini as its newest global athlete partner. As part of the multi-year agreement and official smart wearable partnership, Paolini will represent Amazfit by wearing the Amazfit logo and smartwatch on court and the brand's fitness wearables, including Helio Ring, to track sleep and athletic recovery. This press release features multimedia. View the full release here: https://www.businesswire.com/news/h

    2/18/25 10:00:00 AM ET
    $ZEPP
    Computer Manufacturing
    Technology

    Five-Time Olympic Medalist Gabby Thomas Joins Amazfit as Athlete Ambassador

    Amazfit becomes Thomas' first Smartwatch Partner Amazfit, a leading global smart wearables brand owned by Zepp Health (NYSE:ZEPP), is proud to announce five-time Olympic Medalist and fashion icon, Gabby Thomas, as the latest ambassador to join the brand's growing roster of elite athletes. As part of the four-year partnership, Thomas will wear Amazfit smartwatches both on the track during training and in competition, and off the track to monitor sleep and recovery. Moreover, through the Zepp app-based food log, Gabby will have easy access to nutrition-tracking as well. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250213824479

    2/13/25 12:00:00 PM ET
    $ZEPP
    Computer Manufacturing
    Technology

    $ZEPP
    Financials

    Live finance-specific insights

    View All

    Zepp Health Acquires Core Assets of Wild.AI to Expand Support for Female Athletes Across Life Stages

    Zepp Health (NYSE:ZEPP), the parent company of Amazfit, today announced it has acquired the core assets and intellectual property of Wild.AI, a pioneering women's wellness platform focused on optimizing female performance through hormone-informed coaching. The acquisition was completed at the end of August and includes Wild.AI's proprietary technology and select members of its leadership team. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250904422306/en/ZEPP), the parent company of Amazfit, today announced it has acquired the core assets and intellectual property of Wild.AI, a pioneering women's wellness platform focused on op

    9/4/25 6:42:00 PM ET
    $ZEPP
    Computer Manufacturing
    Technology

    Zepp Health Corporation Reports Second Quarter 2025 Unaudited Financial Results

    MILPITAS, Calif., Aug. 3, 2025 /PRNewswire/ -- Zepp Health Corporation ("Zepp" or the "Company") (NYSE:ZEPP) today announced its unaudited financial results for the second quarter of 2025. Second Quarter 2025 Financial and Operating Highlights: Revenue reached US$59.4 million, representing 46.2% year-over-year growth and surpassing the high end of the guidance range announced previously.GAAP and adjusted net loss[1] was US$7.7 million and US$6.16 million, which narrowed by 28.6% and 30.2% compared with the second quarter of 2024.For the third quarter of 2025, management currently expects net revenues to be between US$72.0 million and US$76.0 million, which would represent a year-over-year i

    8/3/25 9:00:00 PM ET
    $ZEPP
    Computer Manufacturing
    Technology

    Zepp Health Corporation to Report Second Quarter 2025 Financial Results on August 3, 2025

    Earnings Call Scheduled for 9:30 p.m. ET on August 3, 2025 MILPITAS, Calif., July 14, 2025 /PRNewswire/ -- Zepp Health Corporation ("Zepp Health" or the "Company") (NYSE:ZEPP), a global leader in smart wearables and health technology, today announced that it will report its second quarter 2025 unaudited financial results on Sunday, August 3, 2025. Management will hold a conference call at 9:30 p.m. Eastern Time on Sunday, August 3, 2025. Listeners may access the call by dialing: US (Toll Free): +1-888-346-8982 International: +1-412-902-4272 Mainland China (Toll Free): 400-120-1203 Hong Kong (Toll Free): 800-905-945 Hong Kong: +852-3018-4992 Participants should dial in at least 10 minutes b

    7/14/25 7:00:00 AM ET
    $ZEPP
    Computer Manufacturing
    Technology

    $ZEPP
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Zepp Health Corporation

    SC 13G/A - Zepp Health Corp (0001720446) (Subject)

    11/12/24 6:19:43 AM ET
    $ZEPP
    Computer Manufacturing
    Technology

    Amendment: SEC Form SC 13G/A filed by Zepp Health Corporation

    SC 13G/A - Zepp Health Corp (0001720446) (Subject)

    10/4/24 8:26:45 AM ET
    $ZEPP
    Computer Manufacturing
    Technology

    Amendment: SEC Form SC 13G/A filed by Zepp Health Corporation

    SC 13G/A - Zepp Health Corp (0001720446) (Subject)

    10/4/24 8:24:55 AM ET
    $ZEPP
    Computer Manufacturing
    Technology